Guang‐Tao Yan

605 total citations
43 papers, 495 citations indexed

About

Guang‐Tao Yan is a scholar working on Endocrine and Autonomic Systems, Physiology and Epidemiology. According to data from OpenAlex, Guang‐Tao Yan has authored 43 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrine and Autonomic Systems, 10 papers in Physiology and 9 papers in Epidemiology. Recurrent topics in Guang‐Tao Yan's work include Regulation of Appetite and Obesity (16 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Adipose Tissue and Metabolism (7 papers). Guang‐Tao Yan is often cited by papers focused on Regulation of Appetite and Obesity (16 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Adipose Tissue and Metabolism (7 papers). Guang‐Tao Yan collaborates with scholars based in China, Philippines and France. Guang‐Tao Yan's co-authors include Zihui Deng, Hui Xue, Jinying Zhang, Jie Liao, Kai Zhang, Xiuhua Hao, Ji Lin, Hui Xue, Danyang She and Liangan Chen and has published in prestigious journals such as Journal of Cerebral Blood Flow & Metabolism, Chemical Science and European Journal of Pharmacology.

In The Last Decade

Guang‐Tao Yan

41 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guang‐Tao Yan China 13 132 125 104 102 58 43 495
Ayhan Bozkurt Türkiye 16 85 0.6× 50 0.4× 114 1.1× 143 1.4× 32 0.6× 38 626
Zeng-Jin Yang United States 17 65 0.5× 111 0.9× 279 2.7× 55 0.5× 136 2.3× 23 832
Mehmet Erşahin Türkiye 18 226 1.7× 130 1.0× 106 1.0× 182 1.8× 70 1.2× 29 830
Shiu‐Jen Chen Taiwan 13 61 0.5× 84 0.7× 108 1.0× 179 1.8× 13 0.2× 22 481
Hao Tian China 13 47 0.4× 106 0.8× 191 1.8× 155 1.5× 68 1.2× 39 627
Juan Zhu China 15 32 0.2× 62 0.5× 236 2.3× 88 0.9× 110 1.9× 28 682
Ana Beatriz Costa Brazil 7 33 0.3× 105 0.8× 190 1.8× 222 2.2× 57 1.0× 8 601
David Hullin United Kingdom 14 74 0.6× 39 0.3× 157 1.5× 120 1.2× 18 0.3× 33 753
Amani Alghamdi Saudi Arabia 13 34 0.3× 54 0.4× 183 1.8× 135 1.3× 37 0.6× 41 523
Li Hu China 11 32 0.2× 70 0.6× 171 1.6× 65 0.6× 133 2.3× 18 475

Countries citing papers authored by Guang‐Tao Yan

Since Specialization
Citations

This map shows the geographic impact of Guang‐Tao Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang‐Tao Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang‐Tao Yan more than expected).

Fields of papers citing papers by Guang‐Tao Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang‐Tao Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang‐Tao Yan. The network helps show where Guang‐Tao Yan may publish in the future.

Co-authorship network of co-authors of Guang‐Tao Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Guang‐Tao Yan. A scholar is included among the top collaborators of Guang‐Tao Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang‐Tao Yan. Guang‐Tao Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Guang‐Tao, Ziwei Huang, Xinhong Wang, et al.. (2024). Sulfonation metabolism in the gut microbiota is the main metabolic pathway of cholesterol in hypercholesterolemic mice. Food & Function. 15(19). 9750–9765. 4 indexed citations
2.
Yan, Guang‐Tao, Wenwen Tan, Yuhong Liu, et al.. (2024). Berberine alleviates fructose-induced hepatic injury via ADK/AMPK/Nrf2 pathway: A novel insight. Biomedicine & Pharmacotherapy. 179. 117361–117361. 10 indexed citations
3.
Yan, Guang‐Tao, et al.. (2023). High fructose-induced skeletal muscle insulin resistance could be alleviated by berberine via AMPD1 and ADSL. Food and Chemical Toxicology. 175. 113731–113731. 11 indexed citations
4.
Wang, Yan, Jishui Zhang, Wenqi Song, et al.. (2021). A proteomic analysis of urine biomarkers in autism spectrum disorder. Journal of Proteomics. 242. 104259–104259. 13 indexed citations
6.
Deng, Zihui, Jie Liao, Jinying Zhang, et al.. (2014). Inhibition of the Connexin 43 Elevation May be Involved in the Neuroprotective Activity of Leptin Against Brain Ischemic Injury. Cellular and Molecular Neurobiology. 34(6). 871–879. 31 indexed citations
7.
Liao, Jie, Zihui Deng, Lennart Zabeau, et al.. (2013). Leptin attenuates lipopolysaccharide-induced apoptosis of thymocytes partially via down-regulation of cPLA2 and p38 MAPK activation. International Immunopharmacology. 15(3). 620–627. 15 indexed citations
8.
Wu, Qiyan, Jinying Zhang, Zihui Deng, & Guang‐Tao Yan. (2012). [The effect of leptin on Cx43 expression in protecting mice cerebral ischemia/reperfusion injury].. PubMed. 43(3). 314–8.
9.
Deng, Zihui, et al.. (2011). Leptin relieves intestinal ischemia/reperfusion injury by promoting ERK1/2 phosphorylation and the NO signaling pathway. The Journal of Trauma: Injury, Infection, and Critical Care. 72(1). 143–149. 19 indexed citations
10.
Zhang, Jinying, Guang‐Tao Yan, Jie Liao, et al.. (2011). Leptin attenuates cerebral ischemia/reperfusion injury partially by CGRP expression. European Journal of Pharmacology. 671(1-3). 61–69. 42 indexed citations
11.
Liang, Zhixin, et al.. (2011). A Clinical Study on the Effects and Mechanism of Xuebijing Injection () in Severe Pneumonia Patients. Journal of Traditional Chinese Medicine. 31(1). 46–49. 45 indexed citations
12.
Xue, Hui, Guang‐Tao Yan, Ji Lin, & Xiuhua Hao. (2010). [Preliminary investigation of the changes and mechanism of Leptin after myocardial ischemia/reperfusion injury].. PubMed. 22(11). 680–3. 1 indexed citations
13.
Yan, Guang‐Tao, et al.. (2009). Heart-type fatty acid-binding protein is a useful marker for organ dysfunction and leptin alleviates sepsis-induced organ injuries by restraining its tissue levels. European Journal of Pharmacology. 616(1-3). 244–250. 27 indexed citations
15.
Lin, Ji, et al.. (2006). [Effect of long tubular bone fracture on serum levels of leptin, acute phase proteins and biochemical markers for organ functions].. PubMed. 18(1). 19–23. 4 indexed citations
16.
Yan, Guang‐Tao, et al.. (2006). [Changes in serum leptin levels in patients with surgically induced stress responses].. PubMed. 18(3). 172–5. 1 indexed citations
17.
Yan, Guang‐Tao, et al.. (2005). [Distribution of Orexin-A mRNA expression in different organs and its variation in acute inflammation].. PubMed. 17(4). 207–10. 6 indexed citations
18.
Lin, Ji, et al.. (2004). Establishment and Primary Application of a Highly‐Sensitive Orexin‐A Radioimmunoassay. Journal of Immunoassay and Immunochemistry. 25(1). 45–55. 5 indexed citations
19.
Lin, Ji, et al.. (2004). Leptin fluctuates in intestinal ischemia-reperfusion injury as inflammatory cytokine. Peptides. 25(12). 2187–2193. 13 indexed citations
20.
Yan, Guang‐Tao, Xiuhua Hao, Hui Xue, & Yanping Lu. (2002). ESTABLISHMENT OF A HIGHLY SENSITIVE LEPTIN RADIOIMMUNOASSAY AND DETECTION OF INCREASED LEPTIN LEVELS IN HYPERLIPIDEMIA AND PREGNANCY. Journal of Immunoassay and Immunochemistry. 23(3). 317–326. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026